Viking Therapeutics, Inc.
VKTXBiotechnology
$26.86+5.91%As of Oct 29vs prior close
- Market cap
- $3.4B
- P/E (TTM)
- –
- From 52W high
- −36.24%
- EPS (FY25)
- -$3.19
- Revenue (FY25)
- $0
- Dividend yield
- 0.00%
Nomior Score
33
Steady ProfileBottom 19% of the scored universe
Growth—
Quality37
Value—
Momentum30
Resilience40
Growth
$0revenue, FY25
FY16 $0FY25 $0